Best check up doctors in Israel: TOP 5 doctors

Prof. Nadir Arber heads the Cancer Prevention Center at Sourasky Medical Center, specializing in GI cancer prevention and early detection.

• 44 years of experience of experience in gastroenterology and oncology
• Published over 300 research papers on GI cancers
• Fellowship-trained at NewYork-Presbyterian Center
• Member of multiple international cancer research associations

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Erwin Santo pioneered interventional ultrasound in Israel and co-founded the European Society of Gastrointestinal Endoscopy. He leads the Gastroenterological Department at Sourasky Medical Center.

• Expert in diagnosing and treating gastric, liver, and pancreas diseases
• Headed the Interventional Endoscopy Unit at Sourasky Medical Center
• Member of the American Gastroenterological Association and other prestigious organizations

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.